IdentifyGenomics

IdentifyGenomics is a small private genomics tools company developing CRISPR/Cas-based methods to selectively deplete abundant host sequences from DNA and RNA sequencing libraries. Its technology is intended to improve the sensitivity, speed, and cost-effectiveness of metagenomic and microbiome sequencing workflows, particularly for clinical samples with high background human nucleic acid content. Publicly visible information indicates the company pursued an NIH SBIR-funded program focused on removing mitochondrial DNA, ribosomal RNA, and broader human transcriptomic content from sequencing libraries. The business appears to be positioned more as a research and clinical workflow-enablement company than as a therapeutics developer. Available evidence suggests an early-stage platform and IP-driven model rather than a broad clinical drug pipeline.